| ［1］ |
中华医学会眼科学分会角膜病学组.我国过敏性结膜炎诊断和治疗专家共识（2018年）［J］.中华眼科杂志，2018，54（6）：409-414.
|
| ［2］ |
Thong BYH.Allergic conjunctivitis in Asia［J］.Asia Pac Allergy，2017，7（2）：57-64.
|
| ［3］ |
Leonardi A，Silva D，Perez-Formigo D，et al.Management of ocular allergy［J］.Allergy，2019，74（9）：1611-1630.
|
| ［4］ |
Michailopoulos P，Almaliotis D，Georgiadou I，et al.Allergic conjunctivitis in patients with respiratory allergic symptoms；a retrospective study in Greece［J］.Medical Hypothesis，Discovery and Innovation in Ophthalmology，2017，6（1）：3-9.
|
| ［5］ |
陈家利，周华祥，蒋怡，等.过敏性结膜炎中西医治疗进展［J］.中国中医眼科杂志，2020，30（5）：375-378.
|
| ［6］ |
Bielory L，Delgado L，Katelaris CH，et al.ICON：diagnosis and management of allergic conjunctivitis［J］.Ann Allerg Asthma Im，2020，124（2）：118-134.
|
| ［7］ |
Elieh-Ali-Komi D，Rambasek T，Bielory L.Clinical implications of mast cell involvement in allergic conjunctivitis［J］.Allergy，2018，73（3）：528-539.
|
| ［8］ |
宁婵慧，李冰，郑晓汾.T细胞及其细胞因子在过敏性结膜炎作用机制的研究［J］.国际眼科纵览，2015，39（5）：357-360.
|
| ［9］ |
León B，Ballesteros-Tato A.Modulating Th2 cell immunity for the treatment of asthma［J］.Front Immunol，2021，12：637948.
|
| ［10］ |
Iwasaki N，Terawaki S，Shimizu K，et al.Th2 cells and macrophages cooperatively induce allergic inflammation through histamine signaling［J］.Plos One，2021，16（3）：e0248158.
|
| ［11］ |
Shin S，Lee J H，Lee H J，et al.Rapamycin attenuates Th2-driven experimental allergic conjunctivitis［J］.Clin Immunol，2018，190：1-10.
|
| ［12］ |
王静静，宋昕阳，钱友存.白介素-17家族细胞因子的研究进展［J］.生命科学，2016，28（2）：170-181.
|
| ［13］ |
Meng XT，Shi YY，Zhang H，et al.The role of Th17 cells and IL-17 in Th2 immune responses of allergic conjunctivitis［J］.J Ophthalmol，2020：6917185.
|
| ［14］ |
Kinyanjui MW，Shan J，Nakada EM，et al.Dose-dependent effects of IL-17 on IL-13-induced airway inflammatory responses and airway hyperresponsiveness［J］.JImmunol，2013，190（8）：3859-3868.
|
| ［15］ |
Bai MT，Li Y， Hu ZL.Ragweed pollen induces allergic conjunctivitis immunetolerancein mice via regulation of the NF-κB signal pathway［J］.Int J Ophthalmol，2021，14（7）：955-964.
|
| ［16］ |
Chen X，Deng R，Chi W，et al.IL-27 signaling deficiency develops Th17-enhanced Th2-dominant inflammation in murine allergic conjunctivitis model［J］.Allergy，2019，74（5）：910-921.
|
| ［17］ |
Wan X，Zhang Y，Tang H，et al.IL-27 signaling negatively regulates FcζRI-mediated mast cell activation and allergic response［J］.JLeukocyte Biol，2022，112（3）：411-424.
|
| ［18］ |
Kemter AM，Nagler CR.Influences on allergic mechanisms through gut，lung，and skin microbiome exposures［J］.J Clin Invest，2019，129（4）：1483-1492.
|
| ［19］ |
Liang Q，Li J，Zhang S，et al.Characterization of conjunctival microbiome dysbiosis associated with allergic conjunctivitis［J］.Authorea Preprints，2020，76（2）：596-600.
|
| ［20］ |
Zarzuela JC，Reinoso R，Armentia A，et al.Conjunctival intraepithelial lymphocytes， lacrimal cytokines and ocular commensal microbiota：analysis of the three main players in allergic conjunctivitis［J］.Front Immunol，2022，13：911022.
|
| ［21］ |
Zeissig S，Blumberg RS.Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces［J］.Curr Opin Immunol，2013，25（6）：690-696.
|
| ［22］ |
Ivanov II，de Llanos Frutos R，Manel N，et al.Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine［J］.Cell Host Microbe，2008，4（4）：337-349.
|
| ［23］ |
Knoop KA，Newberry RD.Goblet cells：multifaceted players in immunity at mucosal surfaces［J］.Mucosal Immunol，2018，11（6）：1551-1557.
|
| ［24］ |
Portal C，Gouyer V，Gottrand F，et al.Ocular mucins in dry eye disease［J］.Exp Eye Res，2019，186：107724.
|
| ［25］ |
Hodges RR，Dartt DA.Tear film mucins：front line defenders of the ocular surface；comparison with airway and gastrointestinal tract mucins［J］.Exp Eye Res，2013，117：62-78.
|
| ［26］ |
Birchenough GMH，Nyström EEL，Johansson MEV，et al.A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion［J］.Science，2016，352（6293）：1535-1542.
|
| ［27］ |
Wlodarska M，Thaiss CA，Nowarski R，et al.NLRP6 inflammasome orchestrates thecolonic host-microbial interfaceby regulatinggoblet cell mucus secretion［J］.Cell，2014，156（5）：1045-1059.
|
| ［28］ |
Ermund A，Schütte A，Johansson MEV，et al.Studies of mucus in mouse stomach，small intestine，and colon.I.Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches［J］.Am J Physiol-Gastr L，2013，305（5）：G341-G347.
|
| ［29］ |
García-Posadas L，Hodges RR，Diebold Y，et al.Contextdependent regulation of conjunctival goblet cell function by allergic mediators［J］.Sci Rep，2018，8（1）：12162.
|
| ［30］ |
Matsuzawa M，Ando T，Fukase S，et al.The protective role of conjunctival goblet cell mucin sialylation［J］.Nat Commun，2023，14（1）：1417.
|
| ［31］ |
Singh N，Diebold Y，Sahu SK，et al.Epithelial barrier dysfunction in ocular allergy［J］.Allergy，2022，77（5）：1360-1372.
|
| ［32］ |
Cayrol C，Girard JP.IL-33：an alarmin cytokine with crucial roles in innate immunity，inflammation and allergy［J］.Curr Opin Immunol，2014，31：31-37.
|
| ［33］ |
Schmitz J，Owyang A，Oldham E，et al.IL-33，an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines［J］.Immunity，2005，23（5）：479-490.
|
| ［34］ |
Pichery M，Mirey E，Mercier P，et al.Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues，lymphoid organs，brain，embryos，and inflamed tissues：in situ analysis using a novel Il-33-LacZ gene trap reporter strain［J］.J Immunol，2012，188（7）：3488-3495.
|
| ［35］ |
Liew FY，Pitman NI，McInnes IB.Disease-associated functions of IL-33：the new kid in the IL-1 family［J］.Nat Rev Immunol，2010，10（2）：103-110.
|
| ［36］ |
Yasuoka S，Kawanokuchi J，Parajuli B，et al.Production and functions of IL-33 in the central nervous system［J］.Brain Res，2011，1385：8-17.
|
| ［37］ |
Dwyer GK，D'Cruz LM，Turnquist HR.Emerging functions of IL-33 in homeostasis and immunity［J］.Annu Rev Immunol，2022，40（1）：15-43.
|
| ［38］ |
Hu J，Gao N，Zhang Y，et al.IL-33/ST2/IL-9/IL-9R signaling disrupts ocular surface barrier in allergic inflammation［J］.Mucosal Immunol，2020，13（6）：919-930.
|
| ［39］ |
Huang CC，Yang W，Guo C，et al.Anatomical and functional dichotomy of ocular itch and pain［J］.Nat Med，2018，24（8）：1268-1276.
|
| ［40］ |
Oetjen LK，Mack MR，Feng J，et al.Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch［J］.Cell，2017，171（1）：217-228.
|
| ［41］ |
Liu B，Tai Y，Achanta S，et al.IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy［J］.Proceedings of the National Academy of Sciences，2016，113（47）：E7572-E7579.
|
| ［42］ |
Okano M，Hirahara K，Kiuchi M，et al.Interleukin-33-activated neuropeptide CGRP-producing memory Th2 cells cooperate with somatosensory neurons to induce conjunctival itch［J］.Immunity，2022，55（12）：2352-2368.
|
| ［43］ |
Koyasu S，Moro K.Innate Th2-type immune responses and the natural helper cell，a newly identified lymphocyte population［J］.Curr Opin Allergy Cl，2011，11（2）：109-114.
|
| ［44］ |
姚娟，郑晓汾，李冰.胸腺基质淋巴细胞生成素在过敏性结膜炎发病中的作用［J］.国际眼科纵览，2015，39（3）：190-194.
|
| ［45］ |
Kim B，Kim TH.Fundamental role of dendritic cells in inducing Th2 responses［J］.Korean J Intern Med，2018，33（3）：483-489.
|
| ［46］ |
Fallon PG，Ballantyne SJ，Mangan NE，et al.Identification of an interleukin（IL）-25-dependent cell population that provides IL-4，IL-5，and IL-13 at the onset of helminth expulsion［J］.J Exp Med，2006，203（4）：1105-1116.
|
| ［47］ |
Roediger B，Kyle R，Tay SS，et al.IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation［J］.JAllergy Clin Immun，2015，136（6）：1653-1663.e7.
|
| ［48］ |
Drake LY，Iijima K，Kita H.Group 2 innate lymphoid cells and CD 4+T cells cooperate to mediate type 2 immune response in mice［J］.Allergy，2014，69（10）：1300-1307.
|
| ［49］ |
Oliphant CJ，Hwang YY，Walker JA，et al.MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+T cells potentiates type 2 immunity and promotes parasitic helminth expulsion［J］.Immunity，2014，41（2）：283-295.
|
| ［50］ |
Batyrova B，Luwaert F，Maravelia P，et al.PD-1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator-activated receptor-γ［J］.Immun Inflamm Dis，2020，8（1）：8-23.
|
| ［51］ |
Jenkins SJ，Perona-Wright G，Worsley AGF，et al.Dendritic cell expression of OX40 ligand acts as a costimulatory，not polarizing，signal for optimal Th2 priming and memory induction in vivo［J］.JImmunol，2007，179（6）：3515-3523.
|
| ［52］ |
Mortha A， Burrows K.Cytokine networks between innate lymphoid cells and myeloid cells［J］.Front Immunol，2018，9：191.
|
| ［53］ |
Halim TYF，Steer CA，MathäL，et al.Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cellmediated allergic lung inflammation［J］.Immunity，2014，40（3）：425-435.
|
| ［54］ |
Mortaz E，Amani S，Mumby S，et al.Role of mast cells and type 2 innate lymphoid（ILC2）cells in lung transplantation［J］.J Immunol Res，2018：2785971.
|
| ［55］ |
Kim BS，Wang K，Siracusa MC，et al.Basophils promote innate lymphoid cell responses in inflamed skin［J］.J Immunol，2014，193（7）：3717-3725.
|
| ［56］ |
Barlow JL，Peel S，Fox J，et al.IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes（type 2 innate lymphoid cells）and airway contraction［J］.J Allergy Clin Immun，2013，132（4）：933-941.
|
| ［57］ |
Imai Y.Interleukin-33 in atopic dermatitis［J］.J Dermatol Sci，2019，96（1）：2-7.
|
| ［58］ |
Corrigan CJ，Wang W，Meng Q，et al.Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses［J］.J Allergy Clin Immun，2011，128（1）：116-124.
|
| ［59］ |
Wang YH，Angkasekwinai P，Lu N，et al.IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells［J］.J Exp Med，2007，204（8）：1837-1847.
|
| ［60］ |
Cayrol C，Girard JP.Interleukin-33（IL-33）：a nuclear cytokine from the IL-1 family［J］.Immunol Rev，2018，281（1）：154-168.
|
| ［61］ |
Molofsky AB，Savage AK，Locksley RM.Interleukin-33 in tissue homeostasis，injury，and inflammation［J］.Immunity，2015，42（6）：1005-1019.
|
| ［62］ |
Liew FY，Girard JP，Turnquist HR.Interleukin-33 in health and disease［J］.Nat Rev Immunol，2016，16（11）：676-689.
|
| ［63］ |
Morita H，Moro K，Koyasu S.Innate lymphoid cells in allergic and nonallergic inflammation［J］.J Allergy Clin Immun，2016，138（5）：1253-1264.
|
| ［64］ |
Topczewska PM，Rompe ZA，Jakob MO，et al.ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses［J］.Front Immunol，2023，14：1130933.
|
| ［65］ |
Salimi M，Stöger L，Liu W，et al.Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines［J］.J Allergy Clin Immun，2017，140（4）：1090-1100.
|
| ［66］ |
Kim BS，Siracusa MC，Saenz SA，et al.TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation［J］.Sci Transl Med，2013，5（170）：170ra16.
|
| ［67］ |
Salimi M，Barlow JL，Saunders SP，et al.A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis［J］.J Exp Med，2013，210（13）：2939-2950.
|
| ［68］ |
Liu Z，Yang X，Liu X，et al.Analysis of expression of ILC2 cells in nasal mucosa based on animal model of allergic bacterial infection rhinitis［J］.J Infect Public Heal，2021，14（1）：77-83.
|
| ［69］ |
Chen R，Smith SG，Salter B，et al.Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in subjects with asthma［J］.Am J Resp Crit Care，2017，196（6）：700-712.
|
| ［70］ |
Sugita J，Asada Y，Ishida W，et al.Contributions of Interleukin-33 and TSLP in a papain-soaked contact lens-induced mouse conjunctival inflammation model［J］.Immun Inflamm Dis，2017，5（4）：515-525.
|